Antiemetic

DRUG5 trials

Conditions

AcupunctureAdvanced Solid TumorsAnesthesia, Pediatrics, SurgeryCirculating Tumor CellMetastatic Prostate CancerNausea Post ChemotherapyNeuroendocrine TumorsTranscutaneous Electrical Acupoint Stimulation

Phase 1

Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs

TerminatedNCT02592707

IpsenNeuroendocrine Tumors

Start: 2017-03-06End: 2022-02-22Updated: 2023-07-19

Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors (MK-1200-002)

CompletedNCT06242691

Merck Sharp & Dohme LLCAdvanced Solid Tumors

Start: 2024-02-28End: 2025-06-17Updated: 2026-03-06

Phase 2

Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)

NCT03050866

Erasmus Medical CenterCirculating Tumor Cell, Metastatic Prostate Cancer

Start: 2017-02-21End: 2022-08-19Target: 140Updated: 2021-08-20

Phase 4

Comparative Study of Superficial Cervical Plexus Block and Nerve of Arnold Block and Incidence of PONV for Inner Ear Surgery

TerminatedNCT02724033

Indiana UniversityAnesthesia, Pediatrics, Surgery

Start: 2014-05-31End: 2018-09-30Updated: 2020-06-16

Unknown Phase

TRANSCUTANEOUS ELECTRICAL ACUPOINT STIMULATION FOR CISPLATIN- CHEMOTHERAPY INDUCED NAUSEA AND VOMITING

CompletedNCT07509905

Cairo UniversityAcupuncture, Nausea Post Chemotherapy, Transcutaneous Electrical Acupoint Stimulation +1

Start: 2025-10-15End: 2026-02-18Updated: 2026-04-03

Related Papers

Dosimetry and pharmacokinetics of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours.

2024-03-265 citations

A phase I/II study of the safety and efficacy of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours.

2023-09-1817 citations